ACOG speaker: CHOICE leads to LARCs

May 9, 2013

"We need a complete shift in how we offer contraception to patients." So said the Principle Investigator of the CHOICE Project, Jeffery Peipert, MD, vice chair for clinical research at Washington University School of Medicine in St. Louis, at ACOG's 61st annual clinical meeting on Tuesday.

"We need a complete shift in how we offer contraception to patients." So said the Principle Investigator of the CHOICE Project, Jeffery Peipert, MD, vice chair for clinical research at Washington University School of Medicine in St. Louis, at ACOG's 61st annual clinical meeting on Tuesday.

Dr. Peipert delivered the Morton and Diane Stenchever Lecture, "Updates in Contraception from the CHOICE Project," to a crowded ballroom at 4 pm Tuesday.

He explained that the CHOICE Project has involved some 9000 women in and near the city of St. Louis since 2007. The women were offered information about the efficacy of various contraceptive methods and given their choice of method at no cost. When the issue of cost was removed from their decision, they chose long-acting reversible contraception (LARC) about 75% of the time, said Dr. Peipert. In addition to protecting women against unwanted pregnancy, the project also lowered abortion rates, repeat abortion rates, and teen pregnancy rates in the study participants.

Results of the CHOICE Project were published in the May 24, 2012 issue of the New England Journal of Medicine and the December 2012 issue of Obstetrics & Gynecology.